79264508 - ABTIS

Information

  • Trademark
  • 79264508
  • Serial Number
    79264508
  • Registration Number
    6050283
  • Filing Date
    June 19, 2019
    5 years ago
  • Registration Date
    May 12, 2020
    4 years ago
  • Transaction Date
    October 11, 2020
    4 years ago
  • Status Date
    May 12, 2020
    4 years ago
  • Published for Opposition Date
    February 25, 2020
    4 years ago
  • Location Date
    May 12, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    LEWIS, SHAILA E
  • Attorney Docket Number
    I2420.82447U
    Attorney Name
    Paul G. Johnson
    Law Office Assigned Location Code
    M50
  • Owners
Mark Drawing Code
4000
Mark Identification
ABTIS
Case File Statements
  • GS0051: Pharmaceutical agents affecting metabolism; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical products for the treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biotechnological preparations for medical purposes, namely, for the treatment of oncological, metabolic and ophthalmic diseases and disorders; drugs for medical purposes, namely, for treating cancer; drugs for medical purposes, namely, for treating diabetes; drugs for medical purposes, namely, for treating ocular disease; antibodies for medical purposes, namely, for the treatment of oncological, metabolic and ophthalmic diseases and disorders; pharmaceutical compositions for the treatment of oncological, metabolic and ophthalmic diseases and disorders; medicines for human purposes for the treatment of oncological, metabolic and ophthalmic diseases and disorders; nutraceuticals for therapeutic purposes for the treatment of cancer; nutraceuticals for therapeutic purposes for the treatment of diabetes; therapeutic drugs and agents, namely, antibody drug conjugate comprising antibody and chemical compound attached for the treatment of oncological, metabolic and ophthalmic diseases and disorders; anti-cancer preparations
  • GS0421: Research and development of vaccines and medicines; biotechnology research; biological research; crude medicines research; scientific research for medical purposes in the field of cancerous diseases; research on the subject of pharmaceuticals; medical research; clinical research in the field of oncology, metabolic disease and ophthalmology
Case File Event Statements
  • 10/11/2020 - 4 years ago
    27 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 9/17/2020 - 4 years ago
    26 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 9/17/2020 - 4 years ago
    25 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 8/12/2020 - 4 years ago
    24 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 5/12/2020 - 4 years ago
    23 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/25/2020 - 4 years ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/25/2020 - 4 years ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/22/2020 - 4 years ago
    20 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 2/5/2020 - 4 years ago
    19 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 2/5/2020 - 4 years ago
    18 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 2/5/2020 - 4 years ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/23/2020 - 4 years ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/9/2020 - 4 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/8/2020 - 4 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/8/2020 - 4 years ago
    13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/16/2019 - 4 years ago
    12 - REFUSAL PROCESSED BY IB Type: RFNT
  • 10/31/2019 - 4 years ago
    11 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 10/31/2019 - 4 years ago
    10 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 10/12/2019 - 5 years ago
    9 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 10/11/2019 - 5 years ago
    8 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/25/2019 - 5 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW Type: RFWR
  • 9/13/2019 - 5 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 9/12/2019 - 5 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/10/2019 - 5 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/20/2019 - 5 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 8/15/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 8/8/2019 - 5 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR